Furthermore, previous pathological studies have provided conflicting evidence as to whether TDP-43 might be a risk factor or a protective factor in terms of neuropsychiatric symptoms in patients with AD (Vatsavayi et al., 2014; Sennik et al., 2017; Bayram et al., 2019). The gene discussed is TARDBP; the disease is Alzheimer disease.